RDY
Dr. Reddy's Laboratories Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IN
$14.68
+2.62%Next report
Analyst consensus
- Next report date
- Jan 22, 2027
- EPS estimate
- $0.15
- Revenue estimate
- $952.7M
Latest reported
- Last report date
- Oct 23, 2026
- EPS actual
- $0.12
- EPS estimate
- $0.10
- Revenue actual
- $910.9M
- Revenue estimate
- $894.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -11.0%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 23, 2026 | $0.10 | $0.12 | Beat 23.98% | $910.9M |
| Jul 21, 2026 | $0.09 | $0.06 | Miss -34.65% | $835.7M |
| May 12, 2026 | $0.09 | $0.06 | Miss -33.33% | $789.1M |
| Jan 21, 2026 | $0.16 | $0.16 | In line | $970.9M |
| Oct 24, 2025 | $0.18 | $0.19 | Beat 5.56% | $992.1M |
| Jul 23, 2025 | $0.18 | $0.20 | Beat 11.11% | $997.5M |
| May 9, 2025 | $0.20 | $0.22 | Beat 10.00% | $994.5M |
| Jul 27, 2024 | $0.22 | $0.20 | Miss -9.09% | $920.7M |
| Jun 12, 2024 | — | $0.20 | — | $868.6M |
| Oct 27, 2023 | $0.18 | $0.21 | Beat 16.67% | $827.3M |
| Jul 26, 2023 | $0.14 | $0.21 | Beat 47.89% | $821.2M |
| Jun 13, 2023 | — | $0.18 | — | $832.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jan 22, 2027